Product Introduction:
Lipaglyn 4mg Tablet contains Saroglitazar, a dual PPAR (peroxisome proliferator-activated receptor) α/γ agonist. It is primarily used to manage lipid and glucose levels in patients with type 2 diabetes, especially when statin therapy alone is insufficient.
Uses:
-
Diabetic Dyslipidemia: Manages abnormal lipid levels in type 2 diabetes patients.
-
Hypertriglyceridemia: Reduces elevated triglyceride levels in diabetic individuals.
-
Non-Alcoholic Fatty Liver Disease (NAFLD): Assists in treating liver conditions associated with metabolic disorders.
-
Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH): Addresses liver inflammation and damage due to fat accumulation.
Benefits:
-
Lowers triglycerides and LDL (bad cholesterol).
-
Increases HDL (good cholesterol).
-
Enhances insulin sensitivity.
-
Supports liver health in metabolic disorders.
Composition:
-
Active Ingredient: Saroglitazar 4mg
Side Effects:
-
Common: Nausea, headache, mild gastrointestinal discomfort.
-
Less Common: Flatulence, indigestion, abdominal distension, weakness, increased body temperature.
Safety Advice:
-
Pregnancy: Consult a doctor before use; animal studies suggest potential risks.
-
Breastfeeding: Use with caution; consult a healthcare provider.
-
Liver/Kidney Conditions: Exercise caution; dose adjustments may be necessary.
-
Alcohol: Limit intake; excessive consumption can worsen liver health.
-
Children: Not recommended for individuals under 18 years.
Dosage:
-
Typically, 4mg once daily.
-
Take with or without food, preferably at the same time each day.
-
Do not exceed the prescribed dose without medical advice.
Storage:
-
Store in a cool, dry place away from direct sunlight.
-
Keep out of reach of children.
Note: Always follow your healthcare provider’s instructions and inform them of any other medications you are taking to avoid potential interactions.
